Interestingly, most Wnt signaling factors such as β-catenin, Axin, GSK3, and Dvl are regulated by ubiquitination and deubiquitination, and the inhibitors of deubiquitinating enzymes may be applied for cancer therapeutic strategies (61). This evidence concerns the gene DVL1 and cancer.